Security record · archived quarter
ALGN
Align Technology, Inc. · Healthcare · Medical - Devices
4Tracked holders
0Δ holders
3.13MShares held
$454.47MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 3.13M | $454.47M | n/a | n/a |
| Q2 2026 | 154 | -2 | 56.95M | $9.61B | +4 | −5 |
| Q1 2026 | 158 | -3 | 53.10M | $9.09B | +1 | −5 |
| Q4 2025 | 160 | -1 | 51.76M | $8.08B | +1 | −1 |
| Q3 2025 | 23 | +2 | 27.57M | $3.45B | +3 | −2 |
| Q2 2025 | 19 | -1 | 27.12M | $5.13B | +1 | −2 |
| Q1 2025 | 17 | 0 | 12.53M | $1.99B | +2 | −2 |
| Q4 2024 | 17 | 0 | 12.70M | $2.65B | n/a | n/a |
| Q3 2024 | 16 | -2 | 10.06M | $2.56B | n/a | −2 |
| Q2 2024 | 18 | n/a | 8.21M | $1.98B | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Ninety One UK Ltd | 2.13M | -3.5% | $310.12M | 0.7% | ▼ Trim | 4 | SEC ↗ |
| 2 | Assenagon Asset Management S.A. | 964.90K | -23.6% | $140.25M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wealth Enhancement Advisory… | 32.02K | +6.0% | $3.93M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | TD Waterhouse Canada Inc. | 1.21K | -6.6% | $175,898 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 680 holders, 68.43M shares, $11.46B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API